Sign in
4/A

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001234066-03-000007

President and CEO sold 3,000 shares at an average $3.17 ($9,507)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
HARRIS ROBERT B President and CEO 2003-07-17 Sale −900 $3.20 $2,880 53,221 D
HARRIS ROBERT B President and CEO 2003-07-17 Sale −1,200 $3.16 $3,792 52,021 D
HARRIS ROBERT B President and CEO 2003-07-17 Sale −900 $3.15 $2,835 51,121 D
Open-market sales · 3,000 sh · avg $3.17 · $9,507
Loading xslF345X02/primary_doc.xml…